Abnormal uterine Bleeding in Patient Having Thyroid Dysfunction

Introduction: Abnormal uterine bleeding (AUB) occurs in women between menarche and menopause, significantly impacting quality of life and imposing financial burden. Thyroid hormone is associated with a broad spectrum of reproductive disorder ranging from abnormal sexual development through menstrual irregularities, ovulatory cycles to infertility and lactational failure. This is because of interaction of thyroid hormone on female reproductive system. This study is designed to check current magnitude of abnormal uterine bleeding among woman having thyroid dysfunction. Objective: To determine frequency abnormal uterine bleeding among women having thyroid dysfunction Subjects and method: The cross sectional descriptive study is carried out in the department of Gynaecology and Obstetrics at Liaquat University Hospital Hyderabad from august 2019 to December 2019. There were 177 with premenopausal women of thyroid dysfunction were included in this study and abnormal uterine bleeding as poly menorrhoea, oligomenorrhoea and menorrhagia were investigated. Study method including through history taking with emphasis on history and pelvic examination. Results: The average age of the patients was 28.33±5.38 years. Menorrhagia was the commonest abnormal uterine bleeding that was observed in 186(59.89%) women followed by oligomenorrhoea 52(29.38%) and polymenorrhoea 19(10.73%). Menorrhagia was significantly in those women who had hypothyroid dysfunction (p=0.0005). Oligomenorrhoea was significantly high in whose women who had hypothyroid (p=0.0005) and Polymenorrhoea was significantly high in those women who had Hyperthyroidism. Conclusion: Abnormal uterine bleeding is frequently seen to be associated with thyroid dysfunction and in majority of the patients; menstrual abnormality may even precede the occurrence of other clinical signs and symptoms of thyroid dysfunction. Correct diagnosis of ethology of AUB would help in proper management of the patient, treating both the menstrual abnormality along with the thyroid disorder, and would be cost-effective as well.